Table 3 Distribution of signs and symptoms indicating peripheral nervous system involvement in patients with COVID-19
Signs and symptoms indicating peripheral nervous system involvement | No. of patients / Proportion |
|---|---|
Smell/taste impairment | 746 (52·8%) |
Anosmia and ageusia | 477 |
Anosmia/hyposmia | 128 |
Ageusia/dysgeusia | 141 |
Visual impairment | 9 (0·6%) |
Unspecified decreased visual acuity | 8 |
Complete visual loss | 1 |
Oculomotor impairment | 14 (1%) |
Ophthalmoparesis | 7 |
Diplopia | 3 |
Anisocoria | 1 |
Bilateral mydriasis | 1 |
Bilateral abducens palsy | 1 |
Unilateral abducens palsy | 1 |
Facial palsy | 13 (0·9%) |
Bilateral weakness/diplegia | 7 |
Unilateral | 6 |
Other cranial nerve impairment | 32 (2·3%) |
Glossopharyngeal neuralgia | 9 |
Trigeminal neuralgia | 8 |
Tinnitus | 5 |
Decreased hearing | 5 |
Vasoglossopharyngeal neuralgia | 2 |
Dysphagia | 2 |
Reduced tongue movements/tongue deviation | 1 |
Peripheral neuropathies involving trunk and limbs | 353 (24·9%) |
Mixed neuropathy | 247 |
Pure sensitive impairment | 31 |
Paresthesia | 30 |
Hypoesthesia | 1 |
Pure motor impairment | 40 |
Areflexia | 14 |
Distal weakness | 8 |
Tetraparesis | 7 |
Gait difficulties/instability | 6 |
Paraparesis | 3 |
Tetraplegia | 1 |
Paraplegia | 1 |
Neuralgia | 8 |
Limb neuralgia | 7 |
Occipital neuralgia | 1 |
Dysautonomia manifestations | 27 |
Nerve roots and plexus disorders | 145 (10·3%) |
Myopathic involvement | 102 (7·2%) |
Total patients with PNS signs and symptoms | 1414 (100%) |